RishiRaj Sinha: Improving Blood Safety Systems in Resource-Limited Settings
RishiRaj Sinha, Member of Public Health Partnerships Subgroup Working Party at International Society of Blood Transfusion (ISBT), shared a post on LinkedIn about a recent article he and Richard Gammon co-authored, published in Oxford University Press in Laboratory Medicine, adding:
”Honored to share that our review article has been published in Oxford University Press in Laboratory Medicine (2026).
This review highlights the overlooked complexities, ethical challenges, and operational gaps in reactive donor notification and counseling practices within LMIC settings focused on strengthening blood safety systems, donor counselling frameworks, and equitable healthcare practices in resource-limited settings.
I extend my sincere gratitude to Richard Gammon for his constant mentorship throughout this journey.”
Title: Beyond the first call: unveiling the gray areas in reactive donor notification and counseling in lower-middle-income countries—a systematic scoping review
Authors: Rishiraj Sinha, Richard Gammon
Other posts featuring RishiRaj Sinha on Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning